Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Molecular Pharmacology|March 1, 1982
Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidationS G Dahl, M Hjorth, E HoughNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1992
Molecular structure and dynamics of the four 10-hydroxynortriptyline isomersE Heimstad, O Edvardsen, S G DahlEuropean Journal of Pharmacology|December 1, 1976
Anticholinergic and cardiodepressive effects of levomepromazine and two of its metabolites on isolated rat atriaM Passwal, S G Dahl, H RefsumReceptors & Channels|July 17, 1998
Molecular modeling of the endogenous peptide Leu-Ser-Ala-Leu, pindolol, 5-hydroxytryptamine and their interactions with the human 5-hydroxytryptamine1B (5-HT1B) receptorK Kristiansen, O Edvardsen, S G DahlReceptors & Channels|November 8, 2001
Molecular model of the Escherichia coli Na1/H1 antiporter NhaAA W Ravna, I Sylte, S G DahlEuropean Journal of Pharmacology|June 24, 1986
Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor bindingP A Hals, H Hall, S G DahlBiochemical Pharmacology|April 15, 1986
Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor bindingS G Dahl, E Hough, P A HalsCurrent Medicinal Chemistry|August 26, 2011
Templates and models of monoamine transporter proteinsI Sylte, A W Ravna, S G DahlEuropean Journal of Clinical Pharmacology|April 20, 1977
Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrupS G Dahl, R E Strandjord, S SigfussonLife Sciences|January 1, 1988
Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolitesP A Hals, H Hall, S G DahlPageof 7